Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1Phase 1 1

Status

Completed 5Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 3OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Breast Neoplasms 33Neoplasms 25Prostatic Neoplasms 16Colorectal Neoplasms 13Lung Neoplasms 11Multiple Myeloma 9Head and Neck Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Pancreatic Neoplasms 6Neoplasm Metastasis 6Urinary Bladder Neoplasms 5Hematologic Neoplasms 5Gastrointestinal Neoplasms 5Advanced Cancer 5Uterine Cervical Neoplasms 4Smoking Cessation 4Ovarian Neoplasms 4Melanoma 4Leukemia 4Colonic Neoplasms 4Anxiety Disorders 4Triple Negative Breast Neoplasms 3Stomach Neoplasms 3Small Cell Lung Carcinoma 3Recurrence 3Rectal Neoplasms 3Neoplasms, Plasma Cell 3Motor Activity 3Lymphoma, Follicular 3Lymphedema 3

Interventions

Oxaliplatin 14Fluorouracil 11Capecitabine 9Surveys and Questionnaires 8Leucovorin 8Irinotecan 8Cisplatin 8Bevacizumab 8Standard of Care 5Gemcitabine 5Drug Therapy 4S 1 (combination) 3Radiotherapy 3Nivolumab 3Interviews as Topic 3IFL protocol 3Educational Status 3Cyclophosphamide 3Colonoscopy 3Blood Specimen Collection 35,10-methylenetetrahydrofolic acid 3trebananib 2tivozanib 2pembrolizumab 2Taxes 2Remote Patient Monitoring 2Pemetrexed 2Panitumumab 2Ocoxin 2N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Gastrointestinal Neoplasms × Standard of Care × Clear all
NCT07184047 2026-02-20

TOX-FRAIL

Ankara Etlik City Hospital

Completed
72 enrolled
Gastrointestinal

Frailty, Biliary Tract Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Malnutrition, Sarcopenia, Sarcoglycanopathies

NCT05237921 2024-03-19

CEDI

Hospital Beatriz Ângelo

Phase NA Completed
50 enrolled
Gastrointestinal

Cachexia, Gastrointestinal Neoplasms, Malnutrition

NCT03329690 2022-03-18

DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]

Daiichi Sankyo

Phase 2 Completed
233 enrolled 26 charts 1 FDA
Gastrointestinal

Adenocarcinoma, Gastrointestinal Neoplasms

NCT01160367 2018-09-05

Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life

Johns Hopkins University

Phase NA Completed
431 enrolled
Gastrointestinal

Amyotrophic Lateral Sclerosis, Gastrointestinal Neoplasms, Pancreatic Neoplasms

NCT01200316 2017-11-30

Rocking Motion: Physiologic Effect on the Surgical Stress Response

M.D. Anderson Cancer Center

Phase 1 Completed
86 enrolled
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡